Join
Live feed
·
PRReleasevia Quantisnow
NTN Buzztime, Inc. logo

NTN Buzztime Announces Approval of Merger with Brooklyn ImmunoTherapeutics by Stockholders at Special Meeting

ByQuantisnow·Wall Street's wire, on your screen.
NTN· NTN Buzztime, Inc.
Consumer Services
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NTN (NTN Buzztime, Inc.) and more on Quantisnow.